Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biodetection

    PositiveID Prepares Additional M-BAND Systems for Field Testing

    By Global Biodefense StaffJanuary 26, 2015
    Biodefense Strategy
    Share
    Facebook LinkedIn Reddit Email

    PositiveID Corporation announced last week that it is preparing additional M-BAND systems for field deployment and testing. Once deployed, the company will have a total of six M-BAND systems in the field and under evaluation, including the four units delivered to the U.S government during the second half of 2014.

    M-BAND (Microfluidic Bio-agent Autonomous Networked Detector) is currently under evaluation with a large federal government contractor to support the U.S. Department of Defense JUPITR Program. As part of this program, M-BAND is being tested and evaluated to baseline performance, reliability, maintainability, ease of use, and cost of operation to provide the best and most affordable options for the U.S. Army and U.S. Air Force.

    M-BAND currently performs detection for six organisms and three toxins on the Centers for Disease Control’s category A and B select agents list.

    M-BAND was developed under contract with the U.S. Department of Homeland Security Science & Technology directorate, and $30 million of contract funding. M-BAND continuously and autonomously analyzes air samples for the detection of biological airborne threats in the form of bacteria, viruses, and toxins, with results in as little as three hours. Faster time to detection allows the deployment of countermeasures and vaccines more quickly than existing systems, thereby reducing casualties.

    “As we see increased interest from the federal government, specifically DoD and DHS, in biodetection technologies, we are preparing additional M-BAND systems for deployment to monitor air samples for potential biothreats,” said William J. Caragol, PositiveID’s Chairman and Chief Executive Officer. “We believe that procurements for these important technologies will ramp up in 2015, in order to protect our homeland security, both domestically and for our allies and troops abroad.”

    Source: PositiveID press release, adapted.

    Share. Facebook LinkedIn Reddit Email
    Previous ArticleCanadian Ebola Response Team Conducts Exercise
    Next Article Study Maps Travel of H7 Influenza Genes

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Terrorism and the Pandemic: Weaponizing a Public Health Crisis

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023

    Mass Spec for Rapid Detection of Biological Warfare Agents

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.